Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Patricia Donahoe, M.D.

Co-Author

This page shows the publications co-authored by Patricia Donahoe and David Pepin.
Connection Strength

3.262
  1. Müllerian inhibiting substance/anti-Müllerian hormone as a fertility preservation agent. Curr Opin Endocrinol Diabetes Obes. 2018 12; 25(6):399-405.
    View in: PubMed
    Score: 0.790
  2. AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer. Proc Natl Acad Sci U S A. 2015 Aug 11; 112(32):E4418-27.
    View in: PubMed
    Score: 0.627
  3. An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance. Technology. 2013 Sep; 1(1):63-71.
    View in: PubMed
    Score: 0.549
  4. Neoadjuvant Treatment With Müllerian-Inhibiting Substance Synchronizes Follicles and Enhances Superovulation Yield. J Endocr Soc. 2019 Nov 01; 3(11):2123-2134.
    View in: PubMed
    Score: 0.206
  5. Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility. Elife. 2019 06 24; 8.
    View in: PubMed
    Score: 0.205
  6. Müllerian inhibiting substance inhibits an ovarian cancer cell line via ß-catenin interacting protein deregulation of the Wnt signal pathway. Int J Oncol. 2017 Mar; 50(3):1022-1028.
    View in: PubMed
    Score: 0.174
  7. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci U S A. 2017 02 28; 114(9):E1688-E1697.
    View in: PubMed
    Score: 0.174
  8. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis. PLoS One. 2016; 11(6):e0156595.
    View in: PubMed
    Score: 0.166
  9. Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center. J Assist Reprod Genet. 2020 Nov; 37(11):2757-2766.
    View in: PubMed
    Score: 0.056
  10. Mutational Analysis of the Putative Anti-Müllerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2. Endocrinology. 2020 07 01; 161(7).
    View in: PubMed
    Score: 0.055
  11. Müllerian-Inhibiting Substance/Anti-Müllerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2018 11 01; 103(11):4187-4196.
    View in: PubMed
    Score: 0.049
  12. Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone. Reprod Biomed Online. 2018 Nov; 37(5):631-640.
    View in: PubMed
    Score: 0.049
  13. Quantification of Müllerian Inhibiting Substance/Anti-Müllerian Hormone polypeptide by isotope dilution mass spectrometry. Anal Biochem. 2018 11 01; 560:50-55.
    View in: PubMed
    Score: 0.047
  14. Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer. Cell Rep. 2016 07 19; 16(3):657-71.
    View in: PubMed
    Score: 0.042
  15. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer. Curr Mol Med. 2016; 16(3):222-31.
    View in: PubMed
    Score: 0.040
  16. Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2358-63.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.